The global home healthcare market size was estimated at USD 416.4 billion in 2024 and is projected to reach USD 747.70 billion by 2030, growing at a CAGR of 10.21% from 2025 to 2030. This can be attributed to rising demand for cost-effective alternatives to curb rising healthcare costs and growing penetration of virtual and remote care industry.
Increasing treatment cost is one of the prime concerns for governments and health organizations, and hence they are striving to curb healthcare costs. Home healthcare is a cost-efficient alternative to an expensive hospital stay. For instance, as per a report by The Commonwealth Fund, “hospital at home,” programs enable patients to receive acute care at home with fewer complications and over 30% reduction in cost of care. This helps ensure patient comfort and is projected to serve as a high impact rendering driver of the market.
Advancement in technology is expected to favor the market growth. The use of technology, such as telemedicine and remote patient monitoring, is driving innovation in the market. These technologies enable home healthcare agencies to monitor patients remotely and provide timely interventions, which can improve patient outcomes and reduce healthcare costs. The integration of remote patient monitoring devices such as smart sensors, telehealth platforms, medical monitoring devices, and many others is expected to boost the demand for these services globally.
Moreover, the rise in telehealth has made it easier for healthcare providers to deliver quality care outside traditional settings. For instance, according to American Hospital Association article published in December 2021, telehealth visits surged dramatically during the pandemic, with Medicare visits through telehealth increasing from about 840,000 in 2019 to over 52 million in 2020. These technologies not only improve access but also enhance clinical outcomes by enabling continuous monitoring and timely interventions.
Rising awareness of home care facilities and disposable income is leading to demand for home healthcare services. The bed-ridden and old patients opt for home healthcare services and products, as it reduces readmission to hospital and recovery rate is higher in comparison to in-hospital. Companies are also focusing more on untapped countries such as India and China. For instance, Apollo Homecare offers long term plans for various categories such as ortho rehab, heart rehab, neuro rehab, lung rehab, mother & baby care, and elderly care. These programs include medical supervision and personalized healthcare services.
Home healthcare is often more cost-effective than traditional facility-based care. As per the Johns Hopkins University study, have shown that substituting hospital admissions with home care can reduce costs by approximately 19 % to 30% per admission while maintaining similar health outcomes for patients . This financial incentive encourages both payers and providers to invest more heavily in home-based services as a viable alternative.
The COVID-19 pandemic had a substantial impact on market expansion. COVID-19 has raised the demand for patient monitoring in regions such as Asia and MEA because of hospital visit restrictions. Government agencies provided various services to help monitor the condition of COVID-19-infected individuals. For instance, in April 2020, the Ministry of Health of Saudi Arabia released an app designed to track the health of individuals suspected of having COVID-19. During the pandemic, the government made attempts to monitor the health of patients, contributing to the expansion of the market. Moreover, during the post-pandemic period, the growing usage of patient monitoring across MEA is anticipated to boost the market.
The chart below represents the relationship between industry concentration, industry characteristics, and industry participants. The x-axis shows the level of industry concentration, ranging from low to high. The y-axis represents various market characteristics, such as degree of innovation, impact of regulations, industry competition, service and product expansion, level of partnerships and collaboration activities, and regional expansion. For instance, the industry is fragmented, with many service providers entering the market. There is a high degree of innovation, moderate level of merger & acquisitions activities, moderate impact of regulations, and moderate geographical expansion of industry.
The home healthcare industry is experiencing a high degree of innovation. The use of technology, such as telemedicine and remote patient monitoring, is also driving innovation in the market. For instance, in August 2024, LG’s in partnership with Amwell launched the Carepoint TV Kit, which integrates existing LG healthcare TVs with advanced monitoring capabilities. This solution allows healthcare providers to engage with patients remotely, facilitating virtual consultations and monitoring without the need for physical presence. The product enables tasks such as patient admission, discharge processes, and care coordination to be managed efficiently from a centralized location.
Several key players are actively engaging in partnerships and collaborations to foster growth & innovation and improve their competitiveness by combining the expertise & efforts of different organizations. For instance, in October 2023, Elara Caring announced its acquisition of American Family Home Health. This strategic move is part of Elara Caring’s ongoing efforts to expand its footprint in the home health care sector. The acquisition aims to enhance the services offered by Elara Caring and improve patient care across the regions served by both organizations.
The regulatory framework for the home healthcare industry involves compliance with industry-specific guidelines and standards to ensure accuracy and consistency. These regulations cover areas such as licensing requirements for home healthcare providers, accreditation of home healthcare agencies, and reimbursement policies for home care services. For instance, in the U.S., according to federal laws and regulations, each province and territory has its own set of rules and requirements for home healthcare services. These may include requirements for licensing, training, and certification of providers, and rules around the types of services that can be provided and the conditions under which they can be provided
The market is experiencing a significant degree of service expansion as the demand for home-based care services continues to increase. Companies are expanding their services to include a broader range of healthcare services, beyond traditional medical services, and are engaged in investment activities to gain a major market share. For instance, in April 2025, Aster DM Healthcare announced a substantial investment of USD 163.9 million over the next five years aimed at expanding its operations across India. This initiative is part of a broader strategy to enhance healthcare accessibility, affordability, and quality throughout the country. A significant aspect of this expansion is Aster's recent merger with Quality Care India Ltd., which consolidates several prominent hospital brands including CARE Hospitals and KIMSHEALTH. This merger positions Aster among the top three hospital chains in India, boasting a network of 38 hospitals and over 10,000 beds across 27 cities.
Many companies are expanding their services to new cities, regions and countries, driven by factors such as demographic changes, increasing healthcare costs, and the need for more patient-centric care models. For instance, in July 2024, Star Health and Allied Insurance Company has recently expanded its offerings to include home healthcare services across more than 50 cities in India . This initiative is designed to provide healthcare solutions directly to customers in the comfort of their homes, enhancing accessibility and convenience for patients. The company aims to address the growing demand for affordable and efficient healthcare options, particularly as traditional hospital care can often be costly and less accessible.
Based on components, the service segment dominated the market with the largest revenue share of 84.1% in 2024. This segment encompasses a wide range of healthcare services delivered to a patient’s home. This growth can be attributed to the aging population is a major driver; as individuals age, they often require more medical care and assistance with daily activities. According to the U.S. Census Bureau, by 2030, all baby boomers are expected to be over 65, leading to an increased demand for home healthcare services that cater specifically to this demographic’s needs.
Moreover, increased investment in training and certification programs for home health aides ensures a higher standard of care, which enhances patient satisfaction and trust in these services. For instance, the Care Academy provides training for Home Health Aides (HHAs), which is a crucial profession in t he healthcare industry. Home Health Aides play a vital role in supporting patients with various medical conditions, disabilities, or elderly individuals who require assistance with daily living activities.
The diagnostics segment is and anticipated to grow at the fastest CAGR over the forecast period. The growing advancements in technology have facilitated the development of portable diagnostic tools that enable healthcare professionals to conduct tests remotely. This shift not only enhances patient convenience but also reduces the burden on healthcare facilities. Furthermore, the COVID-19 pandemic accelerated the adoption of telehealth services and at-home testing kits, highlighting the importance of diagnostics in managing public health crises. As a result, companies are increasingly investing in innovative diagnostic solutions tailored for home use, contributing to robust market growth. For instance, in March 2023, Cue Health announced the expansion of its Cue Care platform. This expansion included the launch of a suite of at-home diagnostic tests aimed at empowering individuals to manage their health more effectively. The tests are designed to deliver quick and accurate results, which is particularly significant in the context of increasing consumer demand for accessible healthcare solutions.
Based on indication, the neurological & mental disorder segment dominated the market with the largest revenue share of 16.75% in 2024 owing to increasing disease prevalence. Neurological disorders, including epilepsy, Alzheimer's & other dementias, stroke, migraine & other headaches, multiple sclerosis, and Parkinson's disease, can affect the functioning of the brain, spine, and nerves. Home healthcare services, such as physical therapy, occupational therapy, speech therapy, and mental health services, can help those with such disorders manage symptoms. According to the NCBI , in 2022, an estimated 6.5 million people aged 65 and over in the US were suffering from Alzheimer's disease, which is expected to rise to 13.8 million by 2060. In addition, women are more likely to be diagnosed with Alzheimer’s than men due to their longer life expectancy, and it is becoming the most common cause of death in neurodegenerative diseases, as well as a common cause of physical disability that requires urgent treatment.
The mobility disorders segment is expected to grow at the fastest CAGR during the forecast period. According to the CDC, 12.2% of U.S. adults have a mobility-related disability with serious difficulty walking or climbing stairs. Mobility disorders are conditions that limit movement due to physical, psychological, or neurological impairment, and treatment may include physical therapy, assistive devices, and medications. Home healthcare services can provide numerous benefits to individuals with mobility disorders, such as assistance with daily tasks & activities to help maintain independence and physiotherapists to help regain mobility, functionality, strength & reduce pain through exercise, movements, & massage. The increasing prevalence of mobility disorders is expected to drive the growth of this segment over the forecast period.
North America home healthcare market dominated the global market with the largest revenue share of over 42.47% in 2024. The market growth is driven by an increasing geriatric population in this region, coupled with sophisticated healthcare infrastructure and relatively high disposable incomes. Moreover, an increasing number of government initiatives that aim to curb healthcare expenditure levels by promoting home healthcare is expected to serve as a vital impact-rendering driver. In addition, companies are actively engaged in strategic alliances to expand their reach and gain a strong position in the market.
The U.S. market held the largest revenue share in 2024. The increasing FDA initiatives to expand telehealth capabilities, making it easier for patients to consult with healthcare providers remotely. This is particularly important for individuals in rural areas or those with mobility issues who may find it challenging to visit healthcare facilities. For instance, in November 2024, the U.S. FDA announced a new initiative aimed at enhancing access to digital medical care, particularly for underserved populations. This initiative, termed “Health Care at Home,” seeks to leverage technology to improve health equity by ensuring that all individuals, regardless of their socioeconomic status or geographic location, can access quality healthcare services from the comfort of their homes.
The Europe home healthcare market is anticipated to grow significantly due to the high prevalence of CVD. According to the study published by Nation Center for Biotechnology Information (NCBI) in October 2024 , CVD which is a significant public health issue in the European Union (EU), accounting for approximately 11% of the total healthcare expenditure. This statistic highlights the financial burden that CVD places on healthcare systems across member countries. The economic impact is compounded by the high mortality rates associated with CVD, which remains the leading cause of death among countries that are members of the European Society of Cardiology (ESC).
UK home helathcare market is expected to grow significantly over the forecast period. The growth is driven by the growing developments and technological advancements to improve home healthcare facilities. For instance, in January 2023 , Omron Healthcare launched an innovative app named Viso, which has received approval from the National Health Service (NHS) in the UK. This app is designed to assist both patients and healthcare providers in managing chronic conditions such as diabetes, heart disease, and high blood pressure. The development of Viso reflects a growing trend towards digital health solutions that empower patients to take control of their health while facilitating better communication and management strategies between patients and healthcare professionals.
Germany home healthcare market held a significantshare in 2024 due to the growing events which drive company engagement and discussions regarding various chronic diseases. For instance, in November 2023, the formal opening of the CSA BrainHealth program was marked by significant attendance, with over 90 participants present . This event served as a platform for various stakeholders to engage in discussions about brain health and its implications. The program featured presentations from representatives of the European Commission, who outlined the objectives and goals of the CSA (Coordination and Support Action) project. These presentations were crucial in setting the stage for understanding the broader context of brain health within Europe and beyond.
Asia Pacific home healthcare market has been estimated to be the fastest-growing region. Factors such as underdeveloped healthcare infrastructure, expensive in-hospital healthcare facilities, and chronic diseases that require long-term care are resulting in an increase in home healthcare products and services. Thailand, Australia, India, South Korea, and New Zealand are some of the emerging countries in the region. Technological advancements in patient monitoring devices and an increasing geriatric population coupled with the growing prevalence of lifestyle diseases, such as obesity & diabetes, are anticipated to drive the growth of the market.
Japan home healthcare market is experiencing significant growth, driven by its rapidly aging population and the increasing prevalence of chronic diseases. This expansion is fueled by a growing preference among elderly individuals for receiving medical care in the comfort of their homes, advancements in telemedicine and remote monitoring technologies, and supportive government policies aimed at reducing hospital admissions and healthcare costs. Key players in the market include Medtronic Japan, Panasonic Healthcare, Omron Healthcare, and Philips Healthcare .
India home healthcare market is driven by the increasing need for better quality postoperative & primary care, advancement in technologies, rising disposable income, the shift of trend from communicable to lifestyle diseases, and the increasing availability of improved home care services with the technology-enabled platform are expected to drive the market growth. The growing geriatric population & dependency ratio in India is expected to drive the demand for home healthcare. According to the Economic and Social Commission for Asia and the Pacific, the aging population of India is expected to reach 298 million by 2051, accounting for 17% of the national population. With the introduction of advanced home healthcare services in the country, high-quality healthcare can now be delivered in the comfort of one's own home.
The Latin America home healthcare market is anticipated to grow significantly over the forecast period. This growth is driven by the cultural shifts towards valuing family involvement in caregiving have further propelled the demand for home healthcare services. In many Latin American cultures, families play a crucial role in caring for elderly relatives; thus, home healthcare provides a way to support these familial structures while ensuring that professional medical care is available when needed. This trend has been observed particularly during the COVID-19 pandemic when many families opted for home-based care solutions as hospitals became overwhelmed with cases.
Brazil home healthcare market held the largest revenue share in 2024 due to an increasing number of government initiatives to promote home healthcare across the country. In September 2023, the Brazilian government launched the National Development Strategy for the Health Economic-Industrial Complex (CEIS Development Strategy).This initiative is part of a broader effort to enhance Brazil’s self-sufficiency in producing essential health items for its Unified Health System (Sistema Único de Saúde, SUS). The program aims to strengthen the domestic health industry by fostering local production capabilities and reducing reliance on imported medical supplies and pharmaceuticals.
The Middle East and Africa home healthcare market is anticipated to grow significantly during the forecast period. Market growth in this region can be attributed to the increasing prevalence of chronic diseases, and a growing preference for personalized care. One of the primary factors contributing to this expansion is the aging population across many countries in the region.
South Africa home healthcare market is expected to grow significantly over the forecast period the expansion of home healthcare services is the rising incidence of chronic conditions such as diabetes, hypertension, and cardiovascular diseases. The burden of these diseases places immense pressure on the public health system, which often struggles with capacity issues. Home healthcare provides a viable alternative by allowing patients to receive medical attention in their own homes while reducing hospital readmissions and alleviating pressure on healthcare facilities. For instance, organizations such as Life Healthcare have expanded their home care divisions to cater specifically to patients needing ongoing management for chronic illnesses.
The market is highly fragmented due to presence of large number of multinational as well as local market players. Moreover, the consolidation activities such as home healthcare marketing strategies undertaken by multinational companies are estimated to increase competition in home health care industry. Players in the home healthcare market undertake the strategy to strengthen their product portfolios and offer diverse technologically advanced & innovative products to their customers.
Some of the service providers operating in the market are Kindred Healthcare, Inc., Brookdale Senior Living Solutions, Extendicare, Inc., Almost Family, Inc., and others. Some of the suppliers operating in the market includes B. Braun Melsungen AG, Abbott, Sunrise Medical, 3M Healthcare, Baxter International Inc., and others.
Kindred Healthcare, Inc. (Knight Health Holdings, LLC) provides healthcare services in 2,700 locations across 46 states. It has facilities such as transitional care hospitals, inpatient rehabilitation hospitals, nursing centers, subacute units, home health, hospice, and nonmedical home care services.
B. Braun Melsungen AG offers healthcare solutions for emergency care, surgical products, extra corporeal blood treatments, anesthesia, and intensive care units. It provides services and products to hospitals & private clinics.
Some emerging service providers operating in the market includes Sunrise Carlisle, LP (Sunrise Senior Living, LLC), Addus Homecare, Chubb Fire & Security Pty Ltd, and many others. Some of the emerging suppliers operating in the market includes GF Health Products, Inc., Vygon, Teleflex, Inc., and many others.
Vygon manufacturers and markets technologically advanced single-use medical devices. The company operates five business units: critical care, obstetrics neonatology enteral, intravascular therapies, cardiovascular & surgery, and anesthesia & emergency.
Sunrise Carlisle, LP (Sunrise Senior Living, LLC) offers services including assisted living, independent living, care for memory loss & Alzheimer’s, and rehabilitative & nursing services. Sunrise Senior Living, LLC was formed as a successor of Sunrise Senior Living, Inc. (SSLI) in January 2013, which was later acquired by Sunrise Carlisle, LP.
The following are the leading companies in the home healthcare market. These companies collectively hold the largest market share and dictate industry trends.
Suppliers
Service Providers
In August 2024 , Vivid Health entered the at-home care sector with the aim of assisting clinical staff in more effectively completing necessary but labor-intensive assessment forms. This initiative seeks to alleviate staff burnout and enhance operational capacity. Vivid is also working on deploying its solution within three organizations that provide home healthcare or hospital-at-home services.
In July 2024,Star Health and Allied Insurance Company expanded its offerings to include home healthcare services, which are now available in over 50 cities across India. This initiative is part of a broader strategy to enhance accessibility and affordability of healthcare for customers, particularly in the context of rising healthcare costs and the challenges posed by limited infrastructure.
In April 2024,The U.S. FDA initiated a program known as the Home as a Health Care Hub, aimed at transforming the home environment into an integral part of the healthcare system. This initiative is particularly focused on advancing health equity across diverse populations in the U.S., especially those who are underserved or have limited access to traditional healthcare facilities.
In September 2023, Merago partnered with Portea Medical to launch home healthcare services in India. The partnership is expected to provide a range of services including nursing care, physiotherapy, and other medical assistance tailored to individual patient needs and receive personalized care in the comfort of their own homes.
Report Attribute |
Details |
Market size value in 2025 |
USD 459.29 billion |
Revenue forecast in 2030 |
USD 747.70 billion |
Growth rate |
CAGR of 10.21% from 2025 to 2030 |
Actual data |
2018 - 2024 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Component, indication, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Russia; Netherlands; Sweden; Ireland; Switzerland; Denmark; China; Japan; India; Australia; Singapore; Thailand; Philippines; South Korea; Malaysia; New Zealand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; Oman; UAE; Egypt |
Key companies profiled |
B. Braun Melsungen AG; Abbott; Sunrise Medical; 3M Healthcare; Baxter International Inc.; Medtronic PLC; Cardinal Health Inc; F. Hoffmann-La Roche AG; Air Liquide; Amedisys, Inc; NxStage Medical, Inc. (Fresenius Medical Care); Arkray, Inc.; Becton, Dickinson and Company; Omron Healthcare, Inc; Drive DeVilbiss Healthcare; GE Healthcare; Medline Industries, Inc; Koninklijke Philips N.V; Johnson & Johnson Services, Inc.; Linde Healthcare; Acelity (3M); Vygon; Teleflex, Inc; Moog Inc.; Intersurgical Ltd.; Fresenius Kabi AG; Bayer Healthcare; GF Health Products, Inc.; Kindred Healthcare, Inc.; Almost Family, Inc.; National HealthCare Corporation; Chubb Fire & Security Pty Ltd; Gentiva Health Services, Inc.; Medco Home Healthcare, Inc.; Addus Homecare; Brookdale Senior Living Solutions; Sunrise Carlisle, LP (Sunrise Senior Living, LLC); Genesis Healthcare, Inc.; Extendicare, Inc.; SONIDA SENIOR LIVING. (CAPITAL SENIOR LIVING CORPORATION); Diversicare Healthcare Services, Inc.; Home Instead, Inc.; Senior Care Centers of America; Atria Senior Living, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For tthis study, Grand View Research has segmented the global home healthcare market report based on component, indication, and region:
Component Outlook (Revenue, USD Million, 2018 - 2030)
Equipment
Therapeutic
Home respiratory therapy equipment
Insulin delivery devices
Home IV pumps
Home dialysis equipment
Others
Diagnostic
Diabetic care unit
BP monitors
Multi para diagnostic monitors
Home pregnancy and fertility kits
Apnea and sleep monitors
Holter monitors
Heart rate monitors
Others
Mobility Assist
Wheel chair
Home medical furniture
Walking assist devices
Services
Skilled Home Healthcare Services
Physician primary care
Nursing care
Physical/occupational/speech therapy
Nutritional support & infusion therapy
Hospice & palliative care
Others
Unskilled Home Healthcare Services
Indication Outlook (Revenue, USD Million, 2018 - 2030)
Cardiovascular Disorder & Hypertension
Diabetes & Kidney Disorders
Neurological & Mental Disorders
Respiratory Disease & COPD
Maternal Disorders
Mobility Disorders
Cancer
Wound Care
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
Sweden
France
Italy
Russia
Netherlands
Spain
Ireland
Switzerland
Denmark
Asia Pacific
China
Japan
India
Australia
Singapore
Malaysia
Thailand
Philippines
South Korea
New Zealand
Latin America
Brazil
Argentina
Middle East & Africa (MEA)
South Africa
Saudi Arabia
Oman
UAE
Egypt
b. The global home healthcare market size was estimated at USD 416.4 billion in 2024 and is expected to reach USD 459.29 billion in 2025.
b. The global home healthcare market is expected to grow at a compound annual growth rate of 10.21% from 2025 to 2030 to reach USD 747.70 billion by 2030.
b. The service segment dominated the market, with the largest revenue share of 84.1% in 2024.This growth can be attributed to the aging population, which is a major driver; as individuals age, they often require more medical care and assistance with daily activities.
b. Some key players operating in the home healthcare market include VB. Braun Melsungen AG; Abbott; Sunrise Medical; 3M Healthcare; Baxter International Inc.; Medtronic PLC; Cardinal Health Inc; F. Hoffmann-La Roche AG; Air Liquide; Amedisys, Inc; NxStage Medical, Inc. (Fresenius Medical Care); Arkray, Inc.; Becton and others
b. Key factors driving the home healthcare market growth include the rising demand for cost-effective alternatives to curb rising healthcare costs and the growing penetration of the virtual and remote care industry. Increasing treatment costs are one of the prime concerns for governments and health organizations, and hence, they are striving to curb healthcare costs.
NEED A CUSTOM REPORT?
We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.
Request CustomizationWe are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."